Good nnews in new treatments . Regoranfenib already in the market and Zaltrap in a few months!
Published April 05, 2012Dow Jones Newswires
DOW JONES NEWSWIRES
Sanofi SA (SNY) and U.S.-based partner Regeneron Pharmaceuticals Inc. (REGN) Thursday said their experimental drug Zaltrap missed targeted goals in a late-stage clinical trial for treating prostate cancer, but that U.S. regulators are giving it a fast-track review for use in treating colon cancer.
Sanofi said the Phase III VENICE trial involving 1,226 prostate cancer patients "did not meet the pre-specified criterion of improvement in overall survival."
The French drug maker added that the U.S. Food and Drug Administration had granted a priority review to the companies to examine Zaltrap in the treatment of colon cancer. That filing is based on a late-stage study, called VELOUR, in patients with colorectal cancer, whose disease has spread to other parts of the body and who have been previously treated with an oxaliplatin-containing regimen.
A fast-track priority review is given to drugs if preliminary estimates indicate that the product, if approved, has the potential to provide a treatment where no adequate therapy exists or a it shows significant improvement compared with marketed products.
The FDA is due to give a decision on its Zaltra priority review by Aug. 4.
Copyright © 2012 Dow Jones Newswires
Share
inShare
RELATED STOCKS
SHARE THIS ARTICLE
NEWSLETTER SIGNUP
Sign up for free e-mail news alerts from FoxNews.com and FoxBusiness.com.
Comments
-
This is the company my niece works at and that's the drug I got to see in the lab. I made a post back in April with the press release.
Here it is again in it's entirety.
It's nice to see advancements in cancer treatment, even if it may be something that's already been discovered but they found a new application for it, it could be the right drug at the right time...
Thanks for posting again Pepe...
-phil0 -
Thanks to you Phil and thanks to those who are researchingPhillieG said:This is the company my niece works at and that's the drug I got to see in the lab. I made a post back in April with the press release.
Here it is again in it's entirety.
It's nice to see advancements in cancer treatment, even if it may be something that's already been discovered but they found a new application for it, it could be the right drug at the right time...
Thanks for posting again Pepe...
-phil
every day , your nice amog them.
Hugs!0
Discussion Boards
- All Discussion Boards
- 6 CSN Information
- 6 Welcome to CSN
- 121.6K Cancer specific
- 2.8K Anal Cancer
- 445 Bladder Cancer
- 307 Bone Cancers
- 1.6K Brain Cancer
- 28.5K Breast Cancer
- 395 Childhood Cancers
- 27.9K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 13K Head and Neck Cancer
- 6.3K Kidney Cancer
- 669 Leukemia
- 791 Liver Cancer
- 4.1K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 235 Multiple Myeloma
- 7.1K Ovarian Cancer
- 57 Pancreatic Cancer
- 486 Peritoneal Cancer
- 5.4K Prostate Cancer
- 1.2K Rare and Other Cancers
- 536 Sarcoma
- 725 Skin Cancer
- 649 Stomach Cancer
- 191 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.8K Uterine/Endometrial Cancer
- 6.3K Lifestyle Discussion Boards